Featured News

Axios quoted GHTC Director Jamie Bay Nishi in an article on the launch by the World Health Organization (WHO) of the first-ever Essential Diagnostic List.

Learn More
PATH/Nguyen Ba Quang
GHTC sends letter urging House leaders to bolster BARDA’s authority and resources to combat naturally occurring health threats

GHTC sent a letter to the Chairman and Ranking Member of the House Energy and Commerce Committee encouraging them, through the reauthorization of the Pandemics and All-Hazards Preparedness Act, to ensure the Biomedical Advanced Research and Development Authority (BARDA) has ample resources and authority to address emerging infectious diseases (EIDs), pandemic influenza (PI), and antimicrobial resistance (AMR). The letter specifically calls for the creation of a separate funding line of $300 million for EIDS at BARDA, formalization of BARDA’s AMR workstream, and new reporting requirements on the agency’s work in EIDS, PI, and AMR.

PDF
PATH/Will Boase
GHTC WHA statement cited in Homeland Preparedness News

A joint statement developed by GHTC and delivered at the 71st World Health Assembly (WHA) was cited in an article in Homeland Preparedness News.

View
Flickr/Craig Fildes
GHTC submits FY19 testimony to Senate appropriators

GHTC submitted written testimony to key Senate appropriations subcommittees urging them to sustain and protect global health R&D funding in the fiscal year 2019 (FY19) budget. 

Learn More
PATH/Gabe Bienczycki
GHTC analysis referenced in Science

GHTC analysis regarding the implication's of the President's budget proposal on funding for the US Centers for Disease Control and Prevention was cited in an article in Science.

View
PATH/Katrina Peach
GHTC statement on TB high-level meeting delivered at WHA

A statement by GHTC and partners calling for the United Nations High-Level Meeting on Ending TB to issue a political declaration focused on increasing investments in tuberculosis (TB) R&D was delivered at the 71st World Health Assembly (WHA). The statement, which was prepared in partnership with Global Health Council, Infectious Diseases Society of America, Elizabeth Glaser Pediatric AIDS Foundation, and Partners in Health, also encourages the inclusion of child-specific targets for TB R&D and additional resources for R&D to combat drug-resistant TB.

PDF
View All News
PATH/Dan Change
GHTC welcomes launch of first-ever WHO list of essential diagnostic tests

GHTC welcomes the publication today by the World Health Organization (WHO) of its first Essential Diagnostics List, a critical new tool to help guide governments on the vital diagnostic tests that should be made available through health care systems.

Learn More
As White House seeks big cuts in global health research, new state-by-state analysis shows US government investment brings jobs, health security to states while saving millions of lives worldwide

The Trump Administration’s proposal to slash funding to fight global health threats like malaria, Ebola, and HIV/AIDS could cost states thousands of jobs and millions of dollars in economic investment and put the health of residents at risk, according to a new state-by-state analysis released today on Capitol Hill by the Global Health Technologies Coalition.

Learn More
GHTC announces changes to membership structure

GHTC announced today changes to its membership structure to better serve its existing membership and engage a broader group of global health R&D stakeholders in its advocacy activities. Effective now, GHTC will begin offering three types of membership.

Learn More
Flickr/Helena Peixoto
GHTC statement on the President’s FY 2019 budget

The United States has long led the world in developing vaccines, drugs, diagnostics, and other technologies for neglected diseases and conditions that affect the world’s most vulnerable people, and the President’s budget proposal threatens to undermine this scientific and humanitarian legacy.

Learn More
PATH/Patrick McKern
GHTC welcomes House passage of the Global Health Innovation Act

GHTC welcomes yesterday’s passage by the US House of Representatives of the Global Health Innovation Act (H.R. 1660), a bipartisan bill that will strengthen efforts by the US Agency for International Development (USAID) to develop lifesaving drugs, vaccines, and other health technologies for people in need around the world.

Learn More
View All Announcements
WHO/L. Cipriani
WHA Roundup: Incremental steps forward on access and TB takes the limelight

What global health research advocates need to know about the 71st World Health Assembly (WHA).

Read More
Pan American Health Organization
What to watch at WHA 71

The 71st session of the World Health Assembly will see a number of debates that could impact global health R&D. Here is is what you need to know.

Read More
Neil Palmer/CIAT
Preparing the ground in the Brazilian Amazon for a new antimalarial to reduce relapse

Tackling malaria in the Brazilian Amazon has proved challenging. But furtunetly, a solution could be in sight.

Read More
PATH/Gabe Bienczycki
Research Roundup: Polio surveillance gaps and new breakthroughs in Crimean-Congo hemorrhagic fever and preventing HIV transmission

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Mike Wang
Research Roundup: Excess iron may lead to a harder malaria fight, brain damage and Zika in infants, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
View Breakthroughs Blog
PATH/Will Boase
GHTC WHA statement cited in Homeland Preparedness News

A joint statement developed by GHTC and delivered at the 71st World Health Assembly (WHA) was cited in an article in Homeland Preparedness News.

View
PATH/Gabe Bienczycki
GHTC analysis referenced in Science

GHTC analysis regarding the implication's of the President's budget proposal on funding for the US Centers for Disease Control and Prevention was cited in an article in Science.

View
PATH/Gabe Bienczycki
GHTC advocacy on Essential Diagnostic List highlighted in Plus

GHTC's advocacy for an Essential Diagnostic List was cited in an article in Plus, an online magazine of HIV-related news.

View
PATH/Gabe Bienczycki
GHTC director quoted in Devex article previewing debates at WHA

GHTC Director Jamie Bay Nishi was quoted in a Devex article previewing the debates taking place at the 71st World Health Assembly.

View
PATH/Patrick McKern
Contagion quotes GHTC director on launch of Essential Diagnostics List

Contagion quoted GHTC Director Jamie Bay Nishi in article covering the launch of the first-ever Essential Diagnostics List by the World Health Organization.

View
View All GHTC in the Media
PATH/Nguyen Ba Quang
GHTC sends letter urging House leaders to bolster BARDA’s authority and resources to combat naturally occurring health threats

GHTC sent a letter to the Chairman and Ranking Member of the House Energy and Commerce Committee encouraging them, through the reauthorization of the Pandemics and All-Hazards Preparedness Act, to ensure the Biomedical Advanced Research and Development Authority (BARDA) has ample resources and authority to address emerging infectious diseases (EIDs), pandemic influenza (PI), and antimicrobial resistance (AMR). The letter specifically calls for the creation of a separate funding line of $300 million for EIDS at BARDA, formalization of BARDA’s AMR workstream, and new reporting requirements on the agency’s work in EIDS, PI, and AMR.

PDF
Flickr/Craig Fildes
GHTC submits FY19 testimony to Senate appropriators

GHTC submitted written testimony to key Senate appropriations subcommittees urging them to sustain and protect global health R&D funding in the fiscal year 2019 (FY19) budget. 

Learn More
PATH/Katrina Peach
GHTC statement on TB high-level meeting delivered at WHA

A statement by GHTC and partners calling for the United Nations High-Level Meeting on Ending TB to issue a political declaration focused on increasing investments in tuberculosis (TB) R&D was delivered at the 71st World Health Assembly (WHA). The statement, which was prepared in partnership with Global Health Council, Infectious Diseases Society of America, Elizabeth Glaser Pediatric AIDS Foundation, and Partners in Health, also encourages the inclusion of child-specific targets for TB R&D and additional resources for R&D to combat drug-resistant TB.

PDF
PATH/Eric Becker
GHTC statement on access to medicines delivered at WHA

A statement by GHTC and partners calling for the World Health Organization to support a comprehensive approach to addressing barriers to access to medicines was delivered at the 71st World Health Assembly (WHA). The statement, which was prepared in partnership with Global Health Council, American Academy of Pediatrics, NCD Child, and the International Federation of Psoriasis Associations, notes the importance of strengthening regulatory systems and harmonizing processes.

PDF
PATH/Aaron Joel Santos
GHTC issues statement on access to medicines at HHS WHA listening session

GHTC issued a statement at the US Department of Health and Human Services (HHS) World Health Assembly (WHA) Stakeholder Listening Session encouraging the US delegation to support a comprehensive approach to addressing barriers to accessing essential medicines. The statement notes the importance of strengthening regulatory systems and harmonizing processes, as well as encourages the US to support the World Health Organization in better leveraging the expertise of product development partnerships in securing sustainable access comitments. 

PDF
View All Advocacy Actions

Events

Community Event

PATH/Gabe Bienczycki
Empathy: The Emperor’s New Clothes –– or Public Health’s Emerging Superhero?
Matchboxology, USAID Center for Accelerating Innovation and Impact
Learn More

Member Event

RESULTS International Conference
RESULTS
Learn More

Community Event

USAID
Saving Lives at Birth: A Grand Challenge for Development
USAID
Learn More
View All Current & Past Events

Stay Informed

Sign up to receive news and updates from GHTC.
Sign Up Now

Media Inquiries

Marissa Chmiola
Communications Officer
Global Health Technologies Coalition
mchmiola@ghtcoalition.org